Page last updated: 2024-11-12
brl 52974
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 10000638 |
SCHEMBL ID | 7641688 |
MeSH ID | M0233935 |
Synonyms (13)
Synonym |
---|
brl-52974 |
brl 52974 |
145544-79-2 |
5-((3,4-dichlorophenyl)acetyl)-4-(1-pyrrolidinylmethyl)-4,5,6,7-tetrahydro-1h-imidazo(4,5-c)pyridine |
1h-imidazo(4,5-c)pyridine, 5-((3,4-dichlorophenyl)acetyl)-4,5,6,7-tetrahydro-4-(1-pyrrolidinylmethyl)- |
4-(pyrrolidin-1-yl)methyl-5-(3,4-dichlorophenyl)acetyl-4,5,6,7-tetrahydroimidazo[4,5-c]pyridine |
CJLJXCDVYJKDTR-UHFFFAOYSA-N |
SCHEMBL7641688 |
2-(3,4-dichlorophenyl)-1-[4-(pyrrolidin-1-ylmethyl)-1,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl]ethanone |
DTXSID00932635 |
2-(3,4-dichlorophenyl)-1-{4-[(pyrrolidin-1-yl)methyl]-3,4,6,7-tetrahydro-5h-imidazo[4,5-c]pyridin-5-yl}ethan-1-one |
2-(3,4-dichlorophenyl)-1-(4-(pyrrolidin-1-ylmethyl)-6,7-dihydro-3h-imidazo[4,5-c]pyridin-5(4h)-yl)ethanone |
2-(3,4-dichlorophenyl)-1-{4-[(pyrrolidin-1-yl)methyl]-3h,4h,5h,6h,7h-imidazo[4,5-c]pyridin-5-yl}ethan-1-one |
Research Excerpts
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" Initial studies determined the dose-response relationship for each of the two drugs given intraperitoneally twice a day, while monitoring systolic arterial pressure (SAP), mean arterial pressure (MAP) and heart rate (HR) measured by the tail-cuff method." | ( Kappa-opioid receptors behind the blood-brain barrier are involved in the anti-hypertensive effects of systemically administered kappa-agonists in the conscious spontaneously hypertensive rat. Ingenito, AJ; Shen, S, 1999) | 0.3 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |